A. Lyberopoulou

发表

Rates and predictors of HBsAg loss after discontinuation of effective long-term Entecavir or Tenofovir therapy in noncirrhotic HBeAg-negative chronic hepatitis B patients: Results from the DARING-B prospective Greek study

E. Rigopoulou, E. Hadziyannis, G. Papatheodoridis, 2018 .

An Association Study between Hypoxia Inducible Factor-1alpha (HIF-1α) Polymorphisms and Osteonecrosis

K. Malizos, K. Tanimoto, G. Simos, 2013, PloS one.

Programmed cell death-1 rs11568821 and interleukin-28B rs12979860 polymorphisms in autoimmune hepatitis

G. Dalekos, A. Lyberopoulou, N. Gatselis, 2021, Journal of translational autoimmunity.

Prompt initiation of high‐dose i.v. corticosteroids seems to prevent progression to liver failure in patients with original acute severe autoimmune hepatitis

G. Dalekos, A. Lyberopoulou, N. Gatselis, 2018, Hepatology research : the official journal of the Japan Society of Hepatology.

Acute non-A, non-B, non-C hepatitis differences and similarities between hepatitis E virus infection and autoimmune hepatitis, with phylogenetic analysis of hepatitis E virus in humans and wild boars

V. Spyrou, C. Billinis, G. Dalekos, 2022, Annals of gastroenterology.

Significance of serum HBV RNA in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients who discontinue effective antiviral therapy

F. Zoulim, G. Magiorkinis, E. Rigopoulou, 2022, Journal of viral hepatitis.

Impact of genetic and environmental factors on autoimmune hepatitis

G. Dalekos, A. Lyberopoulou, K. Zachou, 2021, Journal of translational autoimmunity.

Soluble IL-2R Levels at Baseline Predict the Development of Severe Respiratory Failure and Mortality in COVID-19 Patients

K. Antoniou, D. Sagris, G. Dalekos, 2022, Viruses.

Evaluation of Two Highly-Multiplexed Custom Panels for Massively Parallel Semiconductor Sequencing on Paraffin DNA

K. Papadopoulou, G. Fountzilas, Z. Alexopoulou, 2015, PloS one.

Low Serum Hepcidin in Patients with Autoimmune Liver Diseases

A. Mamalaki, G. Simos, G. Chachami, 2015, PloS one.

Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg‐negative chronic hepatitis B

F. Zoulim, E. Rigopoulou, B. Testoni, 2020, Journal of viral hepatitis.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

M. Dimopoulos, E. Giannoulatou, H. Gogas, 2016, Oncotarget.

Oxygen-dependent secretion of a bioactive hepcidin-GFP chimera.

E. Paraskeva, G. Simos, K. Pantopoulos, 2013, Biochemical and biophysical research communications.

Enhancer of rudimentary homologue interacts with scaffold attachment factor B at the nuclear matrix to regulate SR protein phosphorylation

I. Mylonis, A. Lyberopoulou, E. Georgatsou, 2017, The FEBS journal.

MgcRacGAP Interacts with HIF-1α and Regulates its Transcriptional Activity

I. Mylonis, G. Simos, G. Chachami, 2007, Cellular Physiology and Biochemistry.

Epigenetic Modifications in Generalized Autoimmune Epithelitis: Sjögren’s Syndrome and Primary Biliary Cholangitis

W. Brooks, Yves Renaudineau, G. Dalekos, 2019, Epigenomes.

MgcRacGAP, a cytoskeleton regulator, inhibits HIF-1 transcriptional activity by blocking its dimerization.

I. Mylonis, G. Simos, G. Papachristos, 2013, Biochimica et biophysica acta.

Altered DNA methylation pattern characterizes the peripheral immune cells of patients with autoimmune hepatitis

Yves Renaudineau, A. Lyberopoulou, M. Ioannou, 2021, medRxiv.